Quick Answer
Nautilus Biotechnology, Inc. reported Shares Outstanding of 126.47 million shares for fiscal year 2025.
Nautilus Biotechnology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 126.47M | +0.3% |
| 2024 | 126.11M | +0.8% |
| 2023 | 125.07M | +0.2% |
| 2022 | 124.87M | +0.5% |
| 2021 | 124.30M | +0.2% |
| 2021 | 124.05M | +275.1% |
| 2020 | 33.07M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 126.31M | +0.6% | +0.0% |
| June 30, 2025 | 126.31M | +0.7% | +0.1% |
| March 31, 2025 | 126.15M | +0.7% | +0.0% |
| December 31, 2024 | 126.11M | +0.8% | +0.4% |
| September 30, 2024 | 125.56M | +0.5% | +0.1% |
| June 30, 2024 | 125.41M | +0.4% | +0.1% |
| March 31, 2024 | 125.27M | +0.3% | +0.2% |
| December 31, 2023 | 125.07M | +0.2% | +0.1% |
- Nautilus Biotechnology, Inc. showed an increase of +0.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Nautilus Biotechnology, Inc.’s shares outstanding has grown by 282.4% (from 33.07 million shares to 126.47 million shares).
- The most recent figure is from Nautilus Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: